NewzResearchers at the Vall d'Hebron Institute of Oncology (VHIO) in Barcelona have developed a method to design personalized cancer immunotherapies using a patient's blood sample. Announced on September 29, the study introduces a new approach to tailoring cancer treatments based on individual biological profiles. This advancement offers the potential to improve therapeutic precision while reducing the complexity of medical procedures involved in cancer care.
In-depth summary · AI, neutral